Tekla Capital Management LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Tekla Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$11.2 - $16.97 $353,852 - $536,150	-31,594 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$12.36 - $18.28 $845,498 - $1.25 Million	-68,406 Reduced 68.41%	31,594 $418,000
Q2 2021 Aug 13, 2021	BUY	$23.12 - $29.91 $1.16 Million - $1.5 Million	50,000 Added 100.0%	100,000 $2.4 Million
Q1 2021 May 14, 2021	BUY	$14.69 - $42.57 $734,500 - $2.13 Million	50,000 New	50,000 $1.29 Million

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $220M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.